Wechseln Sie zum Testsieger und sichern Sie sich bis zu 4.000 € Prämie für Ihr Fondsdepot!-w-
30.11.2021 00:00

Ventricular Assist Devices Market to grow by USD 4.05 billion from 2020 to 2025 | Evolving Opportunities with Abbott Laboratories & Abiomed Inc. | 17000+ Technavio Reports

Folgen
Werbung

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Technavio's latest offering, the Ventricular Assist Devices Market report provides a detailed analysis of the competitive scenario and the market growth across various regions. The ventricular assist devices market value is set to grow by USD 4.05 billion from 2020 to 2025, progressing at a CAGR of 21.46%.

Attractive Opportunities in Ventricular Assist Devices Market by Product and Geography - Forecast and Analysis 2021-2025

For more insights on the Ventricular Assist Devices Market - Download a free sample now!

38% of the market's growth will originate from North America. US and Canada are the key markets for ventricular assist devices in the region. The awareness initiatives by organizations will facilitate the ventricular assist devices market growth in North America. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.

Market Dynamics

The market is driven by factors such as the increasing prevalence of heart failure, and the scarcity of donor's hearts for transplantation.  However, the high costs associated with ventricular assist devices are hindering market growth. The ventricular assist devices market analysis report also provides detailed information on other upcoming trends that will have a far-reaching effect on the market growth.

Company Profiles

The ventricular assist devices market is concentrated and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The ventricular assist devices market report includes information on the product launches, sustainability, and prospects of leading vendors including Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, Calon Cardio-Technology Ltd, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc.

Few Companies with the Key Offerings 

  • Abiomed Inc. - The company is involved in offering a wide range of products such as the OXY-1 System that is a compact cardiopulmonary support system with an integrated oxygen concentrator.
  • Asahi Kasei Corp. - The company is involved in offering a wide range of products such as Defibrillators, AEDs, and many more.
  • Berlin Heart GmbH -The company is involved in offering innovative systems for mechanical circulatory support.

Competitive Analysis

The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Market Segmentation

  • By Product, the market is classified into left and right ventricular assist devices and bi-ventricular assist devices. The ventricular assist devices market share growth by the left and right ventricular assist devices segment has been significant
  • By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.

Related Reports -
Arrhythmia Monitoring Devices Market  -The arrhythmia monitoring devices market share is expected to increase by USD 2.79 billion from 2021 to 2025, and the market's growth momentum will accelerate at a CAGR of 8%. Download a free sample now!

Neuroendoscopy Devices Market  -The global Neuroendoscopy devices market has the potential to grow by USD 127.37 million during 2020-2024, and the market's growth momentum will accelerate throughout the forecast period.Download a free sample now!

Ventricular Assist Devices Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 21.46%

Market growth 2021-2025

USD 4.05 billion

Market structure

Concentrated

YoY growth (%)

16.43

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 38%

Key consumer countries

US, Germany, China, Canada, UK, and India

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, Calon Cardio-Technology Ltd, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

 

Technavio (PRNewsfoto/Technavio)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ventricular-assist-devices-market-to-grow-by-usd-4-05-billion-from-2020-to-2025--evolving-opportunities-with-abbott-laboratories--abiomed-inc--17000--technavio-reports-301432339.html

SOURCE Technavio

Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX schließt tiefer -- US-Börsen unter Druck -- Microsoft kauft Activision -- Siemens verkauft Yunex -- Goldman Sachs verfehlt Erwartungen -- Vonovia will Dividende erhöhen -- AUTO1, CureVac im Fokus

Zweitimpfung bei Johnson & Johnson nötig. BASF-Mehrheitsbeteiligung Wintershall Dea legt Fokus auf Erdgasgeschäft. Flughafen Wien erwartet 2022 Turnaround. Elon Musk kommt Mitte Februar erneut nach Deutschland. Covestro erwirbt restliche Anteile an Japan Fine Coatings. Nordex verzeichnet 2021 deutlich mehr Auftragseingänge. Daimler Truck steigert Absatz 2021 um ein Fünftel.

Umfrage

Haben Sie Verständnis für Menschen, die gegen die Corona-Politik demonstrieren?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln